M. Husbyn

Linear analogues derived from the first EGF‐like domain of human blood coagulation factor VII: enhanced inhibition of FVIIa/TF complex activity by backbone modification through aspartimide formation

A. Cuthbertson, P. Fischer, M. Husbyn, 1999, Journal of peptide science : an official publication of the European Peptide Society.

Peptides corresponding to the second epidermal growth factor-like domain of human blood coagulation factor VII: synthesis, folding and biological activity.

K. Sakariassen, L. Orning, P. Fischer, 2009, The journal of peptide research : official journal of the American Peptide Society.

A Cyclic Pentapeptide Derived from the Second EGF-Like Domain of Factor VII Is an Inhibitor of Tissue Factor Dependent Coagulation and Thrombus Formation

M. Llinás, E. Agner, K. Sakariassen, 2002, Thrombosis and Haemostasis.

Postantibiotic effect and postantibiotic sub‐MIC effect of LTX‐109 and mupirocin on Staphylococcus aureus blood isolates

L. Saravolatz, J. Pawlak, S. Saravolatz, 2017, Letters in applied microbiology.

A novel gene mutation in the 60s loop of human coagulation factor VII – inhibition of interdomain crosstalk

H. Prydz, M. Wiiger, H. Stormorken, 2003, Thrombosis and Haemostasis.

Potassium chlorochromate on a solid support: a convenient and mild reagent for the oxidation of alcohols

I. Löfberg, P. Carlsen, A. Mulichak, 1989 .

Potassium Chlorochromate on a Solid Support: A Convenient and Mild Reagent for the Oxidation of Alcohols.

P. Carlsen, R. Eliason, M. Husbyn, 1989 .

A novel approach to the synthesis of EGF-like domains: a method for the one-pot regioselective formation of the three disulfide bonds of a human blood coagulation factor VII EGF-1 analogue.

A. Cuthbertson, M. Husbyn, 2002, The journal of peptide research : official journal of the American Peptide Society.